SARAH HUDSON-WILLIAMSON: Open Payments
NPI 1194584177 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 45 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $804 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $199 |
| QOL Medical, LLC | 3 | $68 |
| Janssen Biotech, Inc. | 4 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Ardelyx, Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 5 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $20 |
Products named: RINVOQ, Sucraid, TREMFYA, XIFAXAN, IBSRELA, LINZESS, SKYRIZI, ENTYVIO.
Industry payments across KY — which companies pay providers there.
